We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Rexahn Pharmaceuticals, Inc. | AMEX:RNN | AMEX | Ordinary Share |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 5.24 | 0.00 | 01:00:00 |
From Jul 2019 to Jul 2024
Maximizes efficacy and minimizes toxicity of currently marketed anti-cancer drugs
RX-21101 identified as first development candidate from platform
1 Year Rexahn Pharmaceuticals, Inc. Chart |
1 Month Rexahn Pharmaceuticals, Inc. Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
